Medication info
Silverbig Sajeong (Memantine Hydrochloride)

Silverbig Sajeong (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Daewon Biotech Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202000231 · Approved 2020.01.15 · Insurance code 057600540

Summary

Main use
Treatment of moderate-to-severe Alzheimer's disease
Who takes it
Adults
Adult dose
1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, the dose should be increased by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose in patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug to such patients.

Ingredients

Manufacturer
Daewon Biotech Co., Ltd.

Efficacy & effects

Treatment of moderate-to-severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, the dose should be increased by 5mg per week over the first 3 weeks as follows until the maintenance dose is reached. Week 1 (days 1–7): Administer 5mg once daily for 7 days. Week 2 (days 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (days 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). 2. Older adults: Based on clinical data, the recommended dose in patients aged 65 years and older is 20mg daily (10mg twice daily). 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug to such patients.

Precautions

This medication should not be used in patients with an allergy to its components. It should be avoided in patients with severe hepatic dysfunction or severely reduced renal function. It should be used with caution in patients with epilepsy or a history of seizures, and it should not be taken together with other drugs that have similar effects as this may increase side effects. Patients with changes in urinary acidity should be careful while taking this medication, and there is insufficient data for patients with heart disease or uncontrolled hypertension, so caution is advised. During the use of this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if symptoms are severe, consultation with a healthcare professional is necessary. It may interact with other medications, so any drugs being taken should be reported, particularly when taken with antipsychotics, skeletal muscle relaxants, and anticoagulants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and those who are breastfeeding are advised to discontinue breastfeeding. It is advisable not to use this medication in children under 18 years of age, as safety and efficacy have not been established. In case of overdose, central nervous system symptoms and gastrointestinal symptoms may appear, so immediate medical attention should be sought. This medication may slow the response rate of the patient, so care is needed when driving or operating machinery. Lastly, this medication should be kept out of reach of children, and it is important not to transfer it to other containers to maintain its quality.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug allergy
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thromboembolism/thrombosis
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma
  • diplopia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and the storage temperature should be kept at room temperature between 1 to 30 degrees Celsius. In other words, it should not be kept in excessively hot or cold places; storing it safely at the appropriate temperature is essential for maintaining its efficacy.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.